IMI International Medical Innovations
North York, ON
Company Overview
IMI International Medical Innovations, established in 1992, is a predictive medicine company dedicated to developing innovative products for the early detection and monitoring of life- threatening diseases, particularly cancer and cardiovascular disease.
IMIs particular expertise is its ability to identify novel predictive medicine technologies that are in the early stages of development. The company efficiently completes the product development, clinical and regulatory requirements and finally, exploits these technologies for commercial success. IMI has consistently demonstrated an ability to complete this process in a cost effective and timely manner.
The Company will partner with major diagnostic or pharmaceutical companies to manufacture and or market the products on a global basis.
Company Information
Physical Address
615-4211 Yonge St.
North York, ON M2P 2A9
CA
Mailing Address
615-4211 Yonge St.
North York, ON M2P 2A9
CA
Additional Details
Legal Name: IMI International Medical Innovations
Number of Employees: 15
CA
CHOLESTEROL 1, 2, 3 Description: a non-invasive, point of care test for measuring cholesterol levels at the skin surface
This IMI patented technology has the following advantages:
- Does not require blood samples (non-invasive)
- Does not require fasting prior to the test
- Simple three minute procedure
- Immediate point-of-care result, suitable for doctor's office,
clinic, pharmacy or home use.
ColorectAlert Description: a mucous test for detecting early stage colorectal cancer
This patented technology has the following advantages:
- Detects cancer at a stage when patient is symptom-free
- Non-invasive
- Point-of-care result, suitable for doctor's office
LungAlert Description: a non-invasive test that uses a sputum sample for the early detection of lung cancer
Prostate Cancer Test Description: A non-invasive urine based test for the early detection of prostate cancer
Contacts
Ron Hosking
Title: Vice President
Area of Responsibility: Finance/Accounting
Phone: Show phone
Fax: Show fax
Email: Show email
Brent Norton Md Mba
Title: Chief Executive Officer
Area of Responsibility: Management Executive
Phone: Show phone
Fax: Show fax
Email: Show email
Tim Currie
Title: Director
Area of Responsibility: Domestic Sales & Marketing
Phone: Show phone
Fax: Show fax
Email: Show email
Mike Evelegh
Title: Vice President
Area of Responsibility: Research/Development/Engineering
Phone: Show phone
Fax: Show fax
Email: Show email
Products
- Breast Cancer Test
- Cholesterol 1, 2, 3
-
Colorectalert
A mucous based test for the early detection of colorectal cancer
-
Lungalert
A non-invasive sputum based test for the early detection of lung cancer
-
Prostate Cancer
A non-invasive test for the early detection of prostate cancer
NAICS Categories
Additional Information
621510
6550-In Vitro Diagnostic Substances, Reagents, Test Kits and Sets